LIVE

CNMD

CONMED Corporation

CNMD

NYSE·Healthcare·Medical - Devices·Mkt cap $986.4M

$33.83

▲ +3.27%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$31.44 - $56.64

P/E

19.09

Fwd P/E

7.75

Beta

0.92

Div Yield

1.18%

Avg Vol

493.4K

Shares Out

30.8M

Mkt Cap

$986.4M

Price action

Price chart

Down 37.7% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Proprietary minimally invasive surgical technology platforms with strong clinical outcomes and surgeon adoption
  • Established brand portfolio (Hall, CONMED Linvatec, Concept, Shutt) with deep relationships across hospitals and surgery centers
  • Diversified product mix across multiple surgical specialties reduces dependence on single market segment
  • Direct sales force and distributor network providing strong market access and customer relationships
▼

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Steady revenue growth (5% YoY)

Value

Deep value opportunity - significant discount to Medical Devices peers

Momentum

Stable

-0.7% over 3m

Quality

Strong

Strong fundamentals

Dividend

Modest

1.18% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 28, 2026

“
Q2 26 RECAP

APR 29, 2026

Reported EPS of $0.89 vs $0.82 consensus (+8.5% surprise). Revenue of $317.0M vs $310.6M expected (+2.1%). Beat on both top and bottom lines.

EPS beat +8.5%
Rev beat +2.1%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+8.5%

Next: Apr 28, 2026

Revenue trend · last 8Q

—

—

+6%

+3%

+3%

+7%

+8%

-1%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$332.1M

$316.7M

$345.9M

$321.3M

$342.3M

$337.9M

$373.2M

$317.0M

Margins · last 8Q

Gross

—

Operating

—

Profit

4.4%

View full earnings history →

Wall Street consensus

5 analysts · 0% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

0%

Hold

4

80%

Sell

1

20%

Median Price Target

—

Latest: Bank of America · Jun 29, 2026

View full analyst page →

vs Industry

How CNMD stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.